Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan

World Journal of Gastroenterology

Volumn 20, Issue 46, 2014, Pages 17456-17462

  Kuruma, Sawako ^a   Egawa, Naoto ^b   Kurata, Masanao ^a   Honda, Goro ^a   Kamisawa, Terumi ^a   Ueda, Junko ^c   Ishii, Hiroshi ^d   Ueno, Makoto ^e   Nakao, Haruhisa ^c   Mori, Mitsuru ^f   Matsuo, Keitaro ^g   Hosono, Satoyo ^h   Ohkawa, Shinichi ^e   Wakai, Kenji ⁱ   Nakamura, Kozue ^j   Tamakoshi, Akiko ^k   Nojima, Masanori ^f   Takahashi, Mami ^l   Shimada, Kazuaki ^m   Nishiyama, Takeshi ^c   Kikuchi, Shogo ^c   Lin, Yingsong ^c   more..

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e KANAGAWA CANCER CENTER   (Japan)

^f SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j Gifu City Women's College   (Japan)

^k HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^m NATIONAL CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

Case control study; Odds ratio; Pancreatic cancer; Risk; Single nucleotide polymorphisms

Indexed keywords

ADPIOQ GENE; ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; QUESTIONNAIRE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, PANCREATIC DUCTAL; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84918511454     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i46.17456     Document Type: Article

References (33)

1. Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog 2012; 51: 40-52 [PMID: 22162230 DOI: 10.1002/mc.20786]
2. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 2011; 47: 1928-1937 [PMID: 21458985 DOI: 10.1016/j.ejca.2011.03.003]
3. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083 [PMID: 15886696 DOI: 10.1038/sj.bjc.6602619]
4. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134: 95-101 [PMID: 18061176 DOI: 10.1053/j.gastro.2007.10.040]
5. Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM, Chari ST. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 2009; 104: 2318-2325 [PMID: 19513024 DOI: 10.1038/ajg.2009.253]
6. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010; 363: 2339-2350 [PMID: 21142536 DOI: 10.1056/NEJMra0906948]
7. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140 [PMID: 19470990 DOI: 10.1001/jama.2009.726]
8. McCarthy MI. Casting a wider net for diabetes susceptibility genes. Nat Genet 2008; 40: 1039-1040 [PMID: 19165915 DOI: 10.1038/ng0908-1039]
9. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451 [PMID: 15897298 DOI: 10.1210/er.2005-0005]
10. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, Mori H, Jonsson A, Sato Y, Yamagata K, Hinokio Y, Wang HY, Tanahashi T, Nakamura N, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa H, Kashiwagi A, Takeda J, Maeda E, Shin HD, Cho YM, Park KS, Lee HK, Ng MC, Ma RC, So WY, Chan JC, Lyssenko V, Tuomi T, Nilsson P, Groop L, Kamatani N, Sekine A, Nakamura Y, Yamamoto K, Yoshida T, Tokunaga K, Itakura M, Makino H, Nanjo K, Kadowaki T, Kasuga M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 1092-1097 [PMID: 18711367]
11. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng DP, Holmkvist J, Borch-Johnsen K, Jørgensen T, Sandbaek A, Lauritzen T, Hansen T, Nurbaya S, Tsunoda T, Kubo M, Babazono T, Hirose H, Hayashi M, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Tai ES, Pedersen O, Kamatani N, Kadowaki T, Kikkawa R, Nakamura Y, Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 1098-1102 [PMID: 18711366 DOI: 10.1038/ng.208]
12. Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Nabika T, Kasturiratne A, Yamaguchi S, Kono S, Takayanagi R, Yamori Y, Kobayashi S, Ogihara T, de Silva A, Wickremasinghe R, Kato N. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 2010; 53: 299-308 [PMID: 19937311 DOI: 10.1007/s00125-009-1595-1]
13. Okada Y, Kubo M, Ohmiya H, Takahashi A, Kumasaka N, Hosono N, Maeda S, Wen W, Dorajoo R, Go MJ, Zheng W, Kato N, Wu JY, Lu Q, Tsunoda T, Yamamoto K, Nakamura Y, Kamatani N, Tanaka T. Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat Genet 2012; 44: 302-306 [PMID: 22344221]
14. Lin Y, Ueda J, Yagyu K, Ishii H, Ueno M, Egawa N, Nakao H, Mori M, Matsuo K, Kikuchi S. Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer 2013; 13: 337 [PMID: 23835106 DOI: 10.1186/1471-24 07-13-337]
15. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 779-792 [PMID: 21357378 DOI: 10.1158/1055-9965]
16. Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control 2011; 22: 877-883 [PMID: 21445555 DOI: 10.1007/s10552-011-9760-5]
17. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792 [PMID: 16823476 DOI: 10.1172/JCI29126]
18. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, Karmaniolas K, Pelecanos N, Tseleni-Balafouta S, Dionyssiou-Asteriou A, Mantzoros CS. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control 2009; 20: 625-633 [PMID: 19051043 DOI: 10.1007/s10552-008-9273-z]
19. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002; 51: 1247-1255 [PMID: 11916952 DOI: 10.2337/diabetes.51.4.1247]
20. AlSaleh A, O'Dell SD, Frost GS, Griffin BA, Lovegrove JA, Jebb SA, Sanders TA. Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am J Clin Nutr 2011; 94: 262-269 [PMID: 21562092 DOI: 10.3945/ajcn.111.014209]
21. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 179-188 [PMID: 19584347 DOI: 10.1001/jama.2009.976]
22. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 2008; 68: 3178-3184 [PMID: 18451143 DOI: 10.1158/0008-5472.CAN-08-0533]
23. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 2008; 300: 1523-1531 [PMID: 18827209 DOI: 10.1001/jama.300.13.1523]
24. Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, Manson JE, Fuchs CS, Wolpin BM. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst 2013; 105: 95-103 [PMID: 23243202 DOI: 10.1093/jnci/djs474]
25. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12: 17-23 [PMID: 8528244 DOI: 10.1038/ng0196-17]
26. Demolombe S, Franco D, de Boer P, Kuperschmidt S, Roden D, Pereon Y, Jarry A, Moorman AF, Escande D. Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am J Physiol Cell Physiol 2001; 280: C359-C372 [PMID: 11208532]
27. Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, Rösler M, Gerlach U, Heitzmann D, Warth R, Lang F. Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells. Pflugers Arch 2005; 451: 428-436 [PMID: 16133261 DOI: 10.1007/s00424-005-1479-2]
28. Wang H, Miao K, Zhao J, Liu L, Cui G, Chen C, Wang DW, Ding H. Common variants in KCNQ1 confer increased risk of type 2 diabetes and contribute to the diabetic epidemic in East Asians: a replication and meta-analysis. Ann Hum Genet 2013; 77: 380-391 [PMID: 23786590 DOI: 10.1111/ahg.12029]
29. Holmkvist J, Banasik K, Andersen G, Unoki H, Jensen TS, Pisinger C, Borch-Johnsen K, Sandbaek A, Lauritzen T, Brunak S, Maeda S, Hansen T, Pedersen O. The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS One 2009; 4: e5872 [PMID: 19516902 DOI: 10.1371/journal.pone.0005872]
30. Sun Q, Song K, Shen X, Cai Y. The association between KCNQ1 gene polymorphism and type 2 diabetes risk: a meta-analysis. PLoS One 2012; 7: e48578 [PMID: 23133642 DOI: 10.1371/journal.pone.0048578]
31. Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Cochrane BB, Pollak MN, Manson JE, Giovannucci EL, Fuchs CS. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 2013; 105: 1027-1035 [PMID: 23847240 DOI: 10.1093/jnci/djt123]
32. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005; 294: 2872-2878 [PMID: 16352795 DOI: 10.1001/jama.294.22.2872]
33. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202 [PMID: 15644546 DOI: 10.1001/jama.293.2.194]